Oruka Therapeutics, Inc. (ORKA) EBITDA

quarterly EBITDA:

-$20.98M+$7.14M(+25.38%)
March 31, 2025

Summary

  • As of today (July 29, 2025), ORKA quarterly EBITDA is -$20.98 million, with the most recent change of +$7.14 million (+25.38%) on March 31, 2025.
  • Over the past year, ORKA quarterly EBITDA has dropped by -$14.12 million (-205.74%).
  • ORKA quarterly EBITDA is now -205.74% below its all-time high of -$6.86 million, reached on March 31, 2024.

Performance

ORKA quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherORKAincome statement metrics

TTM EBITDA:

-$70.59M-$14.12M(-25.00%)
March 31, 2025

Summary

  • As of today (July 29, 2025), ORKA TTM EBITDA is -$70.59 million, with the most recent change of -$14.12 million (-25.00%) on March 31, 2025.
  • Over the past year, ORKA TTM EBITDA has dropped by -$63.73 million (-928.63%).
  • ORKA TTM EBITDA is now -928.63% below its all-time high of -$6.86 million, reached on March 31, 2024.

Performance

ORKA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherORKAincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ORKA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year--205.7%-928.6%
3 y3 years--205.7%-928.6%
5 y5 years--205.7%-928.6%

ORKA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-205.7%+25.4%-928.6%at low
5 y5-year-205.7%+25.4%-928.6%at low
alltimeall time-205.7%+25.4%-928.6%at low

ORKA EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$20.98M(-25.4%)
-$70.59M(+25.0%)
Sep 2024
-
-$28.12M(+30.8%)
-$56.48M(+99.2%)
DateAnnualQuarterlyTTM
Jun 2024
-
-$21.49M(+213.2%)
-$28.36M(+313.2%)
Mar 2024
-
-$6.86M
-$6.86M

FAQ

  • What is Oruka Therapeutics, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Oruka Therapeutics, Inc.?
  • What is Oruka Therapeutics, Inc. quarterly EBITDA year-on-year change?
  • What is Oruka Therapeutics, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Oruka Therapeutics, Inc.?
  • What is Oruka Therapeutics, Inc. TTM EBITDA year-on-year change?

What is Oruka Therapeutics, Inc. quarterly EBITDA?

The current quarterly EBITDA of ORKA is -$20.98M

What is the all time high quarterly EBITDA for Oruka Therapeutics, Inc.?

Oruka Therapeutics, Inc. all-time high quarterly EBITDA is -$6.86M

What is Oruka Therapeutics, Inc. quarterly EBITDA year-on-year change?

Over the past year, ORKA quarterly EBITDA has changed by -$14.12M (-205.74%)

What is Oruka Therapeutics, Inc. TTM EBITDA?

The current TTM EBITDA of ORKA is -$70.59M

What is the all time high TTM EBITDA for Oruka Therapeutics, Inc.?

Oruka Therapeutics, Inc. all-time high TTM EBITDA is -$6.86M

What is Oruka Therapeutics, Inc. TTM EBITDA year-on-year change?

Over the past year, ORKA TTM EBITDA has changed by -$63.73M (-928.63%)
On this page